Adis JournalsBrowse
Summary Slide.png (101.86 kB)
Download file

Safety and Effectiveness Analysis of Dolutegravir in Patients with HIV-1: Interim Report of Post-Marketing Surveillance in Japan

Download (101.86 kB)
media
posted on 2021-07-15, 14:06 authored by Adis Rapid Journals on behalf of:, Haruyuki Hongo, Takako Nagao, Kyoko Nakamura, Tomomi Kitaichi, Yuko Maeno, Teruhisa Tokunaga, Akiko Fukuda, Ichiro Koga

Article full text


The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2021.

History

References

Usage metrics

Read the peer-reviewed publication

Safety and Effectiveness Analysis of Dolutegravir in Patients with HIV-1: Interim Report of Post-Marketing Surveillance in Japan
Advances in TherapyAdvances in Therapy

Categories

Keywords

antiretroviral therapydolutegravireffectivenesshuman immunodeficiency virusintegrase strand transfer inhibitorpost-marketing surveillancesafety

Licence

CC BY-NC 4.0

Exports